Otofarma S.P.A. Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	2.23	0.74
Cash & Short-Term Investments	2.23	0.74
Cash Growth	203.30%	-
Accounts Receivable	2.71	2.61
Other Receivables	2.29	1.65
Receivables	5	4.26
Inventory	0.34	0.23
Total Current Assets	7.57	5.22
Property, Plant & Equipment	0.38	0.21
Long-Term Investments	0.62	0.61
Other Intangible Assets	0.03	-
Long-Term Deferred Charges	0.59	-
Other Long-Term Assets	0.1	0.1
Total Assets	9.28	6.15
Accounts Payable	1.54	1.45
Accrued Expenses	0.25	0.14
Current Portion of Long-Term Debt	0.74	0.65
Current Income Taxes Payable	0.82	0.19
Other Current Liabilities	0.04	0.03
Total Current Liabilities	3.38	2.46
Long-Term Debt	0.92	0.84
Long-Term Unearned Revenue	0.02	0.02
Other Long-Term Liabilities	0.21	0.18
Total Liabilities	4.54	3.5
Common Stock	1.1	1.1
Retained Earnings	3.64	1.54
Comprehensive Income & Other	0	0
Shareholders' Equity	4.74	2.64
Total Liabilities & Equity	9.28	6.15
Total Debt	1.66	1.49
Net Cash (Debt)	0.57	-0.75
Net Cash Growth	-	-
Working Capital	4.18	2.76
Tangible Book Value	4.71	2.64
Land	0.22	0.03
Machinery	0.26	0.26